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Purpose/Objective: To study the dosimetric parameters of 
dose rate constant, radial dose functions and anisotropy 
functions for the model BT-125-1 125I seed with 
thermoluminescent dosimeters. 
Materials and Methods: The preliminary experiment is to 
study repeatability, linearity of dose response, dose rate 
effect and energy response of the thermoluminescent 
dosimeters (TLD). The seed was placed perpendicularly in the 
center of the PMMA phantom, and 12 TLDs were placed 
parallel to the source long axis at radial distance of 1 cm 
with 30°increments, to study the dose rate constant of the 
model BT-125-1 125I seed; the TLDs were placed at radial 
distances of 0.5, 0.7, 1.0 to 10.0 cm with a 0.5 cm increment 
and a 5° step, to study the radial dose functions of the model 
BT-125-1 125I seed. The seed was placed horizontally in the 
center of the PMMA phantom, and the TLDs were placed 
vertically to the longitudinal axis of the seed at radial 
distances of 0.5, 1, 1.5, 2, 3 to 7 cm with a 1 cm increment, 
and polar angles in 20° increments at the radial distance of 
0.5 cm, while polar angles in 10° increments at the other 
radial distances, to study the anisotropy functions of the 
model BT-125-1 125I seed. 
Results: For the model BT-125-1 125I seed, the maximum 
deviation of repeatability for TLDs was 4.0%. The TLDs had 
linear dose response without dose rate effect, but the dose 
response is energy dependent. The dose rate constant, radial 
dose functions and anisotropy functions were similar to the 
model 6711 125I presented in the TG43 U1 report.  
Conclusions: The thermoluminescent dosimetry presented 
the dose rate constant, radial dose functions and anisotropy 
functions of the model BT-125-1 125I seed which were similar 
to those of model 6711 125I seed presented in the TG43U1 
report. 
   
EP-1388   
Machine-geometry constancy test for stereotactic radiation 
therapy with ArcCHECK 
S. Wegener1, C. Groh1, O.A. Sauer1 
1University Hospital, Radiation Oncology, Würzburg, 
Germany  
 
Purpose/Objective: The aim of stereotactic radiation 
therapy (SRT) is a highly conformal dose distribution with 
steep gradients around a small PTV. To achieve this, a typical 
SRT plan combines several small coplanar and non-coplanar 
fields. Checks of the linac geometry are required on a regular 
basis to assure a precise dose delivery to the patient. We 
performed weekly measurements of a SRT plan over a period 
of six months and identified some characteristics of the dose 
distribution on the ArcCHECK that could be used as a 
constancy test. Furthermore, we wanted to determine the 
sensitivity to a change in the linac configuration. 
Materials and Methods: A plan for a spherical PTV (approx. 3 
cm in diameter) was delivered about once a week to the 
ArcCHECK (SNC) using an Elekta Synergy with an Agility MLC. 
The plan consists of twelve fields with different gantry angles 
including five iso-centric table rotations. For each 
measurement, a gamma analysis of the dose distribution 
measured on the phantom and the dose calculated by the TPS 
was performed with the SNC software for a variety of 
different gamma criteria. In addition to the measurements, 
plans with small inaccuracies (slightly altered 
gantry/collimator/table angles, shift of the phantom 
position, changed field size) were generated in the TPS to get 
an understanding of their effects on the dose map. Finally, 
measurements of plans with setup errors were taken to 
compare them to the test series. 
Results: Small geometric changes could not be detected by 
simply looking at the percentage of points failing the gamma 
analysis for all criteria tested. However, for certain gamma 
criteria, e.g. (10%, 1.5mm), it could be observed that some 
points failed very reproducibly in all or most measurements, 
generating a typical 'fingerprint' of the plan to be used as a 
constancy check for the machine state. Measurements of 
plans with errors confirmed that different points than usual 
failed the analysis. Moreover, out of geometric considerations 
and from plan comparisons it was obvious that typical 
patterns of failing points could be observed depending on the 
type of error. This could help to identify the cause of an 
error in a measurement resulting in a constancy test that not 
only warns about changes in the linac geometry but also gives 
some hints about the cause of the change. 
Conclusions: A simple constancy test for SRT with the 
ArcCHECK was successfully introduced. Limited mechanical 
accuracy of a clinical linac and limited dose calculation 
accuracy, both lead to non-perfect gamma failing rates. 
Instead of a gamma pass rate, the positions and the 
constancy of deviation of failing points need to be considered 
and might even help to identify which machine parameter 
has to be re-adjusted. A bespoke analysis of the ArcCheck 
dose distribution, in order to quantify the observed 
deviations is currently being implemented. 
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Purpose/Objective: The aim of the study was to investigate 
the performances of Octavius® 4D system with Seven29 and 
1000 SRS arrays (PTW, Germany) in patient-specific QA for 
step and shoot IMRT treatments delivered with the VERO 
system.  
Materials and Methods: The patient-specific QA of 10 clinical 
IMRT plans were compared using the two detectors (seve29 
resolution: 10 mm; 1000 SRS resolution 2.5 mm). All the plans 
were calculated with iPlan 4.5.3 (BrainLab, Germany) with a 
calculation grid of 2 mm on a mathematical phantom, and 
the dose distributions on selected axial, coronal and sagittal 
planes were compared with the corresponding reconstructed 
dose distributions obtained from the measurements with the 
